Home Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss
Article
Licensed
Unlicensed Requires Authentication

Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss

  • Kavita Swachia EMAIL logo , Dinesh Sharma and Jatinder Singh
Published/Copyright: January 14, 2016

Abstract

Background: The current standard treatment for sudden sensorineural hearing loss (SSNHL) comprises of tapered course of oral corticosteroids. Intratympanic steroids are introduced as another modality of treatment, but management of SSNHL continues to be debatable. The present study was designed to evaluate the efficacy of steroids given orally and by the intratympanic route.

Methods: A prospective, randomized, open-labeled study was conducted involving 42 patients. These were randomly divided into two groups; group I patients received oral prednisone tapered over 14 days, and group II patients were treated with intratympanic methylprednisolone (40 mg/mL). One milliliter of the drug solution containing 40 mg of the drug (40 mg/mL) was injected into the middle ear cavity through the trans-tympanic route. The drug was injected twice a week for 2 weeks. The total duration of the study was 60 days, and hearing outcome was assessed on the basis of change in pure tone average.

Results: An improvement of 18.24±8.72 dB was recorded in group I patients treated with oral prednisone in comparison to 14.68±12.88 dB improvement in group II. Statistically significant improvement in hearing was observed in both groups, but it was not significant when group I and group II were compared.

Conclusions: The post-treatment outcomes among patients who receive either oral prednisone or intratympanic methylprednisolone within 2 weeks of onset of symptoms were comparable. The outcomes were affected by degree of hearing loss and association of SSNHL with vertigo.


Corresponding author: Dr. Kavita Swachia, Department of Pharmacology, Government Medical College, Amritsar, India, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Saunders JE, Luxford WM, Devgan KK, Fetterman BL. Sudden hearing loss in acoustic neuroma patients. Otolaryngol Head Neck Surg 1995;113:23–31.10.1016/S0194-5998(95)70140-0Search in Google Scholar

2. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(3 Suppl):S1–35.10.1177/0194599812436449Search in Google Scholar PubMed

3. Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833–40.10.1056/NEJMcp0802129Search in Google Scholar PubMed

4. Browning GG. Sudden sensorineural hearing loss is a modest predictor of future stroke. Clin Otolaryngol 2009;34:157.10.1111/j.1749-4486.2009.01913.xSearch in Google Scholar PubMed

5. Filipo R, Attanasio G, Cagnoni L, Masci E, Russo FY, Cartocci G, et al. Long-term results of intratympanic prednisolone injection in patients with idiopathic sudden sensorineural hearing loss. Acta oto-laryngologica 2013;133:900–4.10.3109/00016489.2013.788791Search in Google Scholar PubMed

6. Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001;125:142–6.10.1067/mhn.2001.117162Search in Google Scholar PubMed

7. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453–60.10.1097/MAO.0b013e318168da7aSearch in Google Scholar PubMed

8. Parnes LS, Sun A, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1–17.10.1097/00005537-199907001-00001Search in Google Scholar PubMed

9. Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. J Am Med Assoc 2011;305:2071–9.10.1001/jama.2011.679Search in Google Scholar PubMed

10. Bennett M, Kertesz T, Yeung P. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss and tinnitus: a systematic review of randomized controlled trials. J Laryngol Otol 2005;119:791–8.10.1258/002221505774481246Search in Google Scholar PubMed

11. Kallinen J, Laurikainen E, Laippala P, Grenman R. Sudden deafness: a comparison of anticoagulant therapy and carbogen inhalation therapy. Ann Otol Rhinol Laryngol 1997;106:22–6.10.1177/000348949710600104Search in Google Scholar PubMed

12. Lee DH. Re: comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases. Clin Otolaryngol 2011;36:395–6.10.1111/j.1749-4486.2011.02338.xSearch in Google Scholar PubMed

13. Samim E, Kilic R, Ozdek A, Gocmen H, Eryilmaz A, Unlu I. Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases. Eur Arch Otorhinolaryngol 2004;261:187–90.10.1007/s00405-003-0659-ySearch in Google Scholar PubMed

14. Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol 2002;23:301–8.10.1097/00129492-200205000-00012Search in Google Scholar PubMed

15. Westerlaken BO, Stokroos RJ, Dhooge IJ, Wit HP, Albers FW. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol 2003;112:993–1000.10.1177/000348940311201113Search in Google Scholar PubMed

16. Wilkins SA Jr, Mattox DE, Lyles A. Evaluation of a “shotgun” regimen for sudden hearing loss. Otolaryngol Head Neck Surg 1987;97:474–80.10.1177/019459988709700508Search in Google Scholar PubMed

17. Byl FM Jr. Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 1984;94:647–61.10.1288/00005537-198405000-00014Search in Google Scholar

18. Nosrati-Zarenoe R, Hansson M, Hultcrantz E. Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome. Acta Otolaryngol 2010;130:384–91.10.3109/00016480903161541Search in Google Scholar

19. Furuhashi A, Matsuda K, Asahi K, Nakashima T. Sudden deafness: long-term follow-up and recurrence. Clin Otolaryngol Allied Sci 2002;27:458–63.10.1046/j.1365-2273.2002.00612.xSearch in Google Scholar PubMed

20. Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope 1977;87:817–25.10.1002/lary.5540870515Search in Google Scholar PubMed

21. Raghunandhan S, Agarwal AK, Natarajan K, Murali S, Kumar RA, Kameswaran M. Effect of intravenous administration of steroids in the management of sudden sensori-neural hearing loss: our experience. Indian J Otolaryngol Head Neck Surg 2013;65:229–33.10.1007/s12070-012-0506-9Search in Google Scholar PubMed PubMed Central

22. Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif 2011;15:91–105.10.1177/1084713811408349Search in Google Scholar PubMed PubMed Central

23. Bae SC, Noh HI, Jun BC, Jeon EJ, Seo JH, Park SY, et al. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Acta Otolaryngol 2013;133:428–33.10.3109/00016489.2012.749520Search in Google Scholar PubMed

24. Chang NC, Ho KY, Kuo WR. Audiometric patterns and prognosis in sudden sensorineural hearing loss in southern Taiwan. Otolaryngol Head Neck Surg 2005;133:916–22.10.1016/j.otohns.2005.09.018Search in Google Scholar PubMed

25. Filipo R, Attanasio G, Russo FY, Viccaro M, Mancini P, Covelli E. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope 2013;123:774–8.10.1002/lary.23678Search in Google Scholar PubMed

26. Spear SA, Schwartz SR. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145:534–43.10.1177/0194599811419466Search in Google Scholar PubMed

Received: 2015-9-12
Accepted: 2015-11-12
Published Online: 2016-1-14
Published in Print: 2016-6-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Assessment of paediatric pain: a critical review
  4. Can genotype determine the sports phenotype? A paradigm shift in sports medicine
  5. Oxidative Stress
  6. Neuroprotective effect of Decalepis hamiltonii on cyclophosphamide-induced oxidative stress in the mouse brain
  7. Hydroxycitric acid ameliorates high-fructose-induced redox imbalance and activation of stress sensitive kinases in male Wistar rats
  8. Metabolism
  9. Glucose absorption in the intestine of albino rats
  10. Inflammation
  11. Antinociceptive and anti-inflammatory potentials of kolaviron: mechanisms of action
  12. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss
  13. Evaluation of antinociceptive and anti-inflammatory properties of methanolic crude extract of Lophopetalum javanicum (bark)
  14. Anti-nociceptive and anti-inflammatory effects of Withania somnifera root in fructose fed male rats
  15. Phytotherapy
  16. Biflavonoid fraction from Garcinia kola seed ameliorates hormonal imbalance and testicular oxidative damage by anti-tuberculosis drugs in Wistar rats
  17. Protective effect of Scutellaria species on AAPH-induced oxidative damage in human erythrocyte
  18. Miscellaneous
  19. Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats
  20. Hormonal and organ-specific dysfunction induced by the interaction between titanium dioxide nanoparticles and salicylic acid in male mice
  21. Case Report
  22. Blood pressure variability and baroreflex sensitivity of a healthy male during cold pressor test that induced development of neurocardiogenic syncope
Downloaded on 1.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2015-0112/html
Scroll to top button